Report error Found 54 Enz. Inhib. hit(s) with all data for entry = 50014295
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 100nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 500nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 600nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 800nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.40E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.90E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.30E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.50E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.80E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.80E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.00E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.20E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.30E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.50E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.60E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.60E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.90E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 4.00E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 4.80E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 4.80E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 5.30E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 5.80E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 8.90E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 9.20E+3nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.10E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.20E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.50E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.60E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.70E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.75E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.80E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.20E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.20E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.60E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 2.90E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair
TargetNeuropeptide Y receptor type 2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3.00E+4nMAssay Description:Binding affinity towards the NPY Y2 receptorMore data for this Ligand-Target Pair

















































